Detalhe da pesquisa
1.
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.
Cell
; 173(2): 515-528.e17, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625057
2.
Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression.
Cancer Res
; 81(20): 5161-5175, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470779
3.
Correction: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.
Cancer Res
; 83(7): 1159, 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014044
4.
ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.
Cancer Res
; 77(4): 1035-1046, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082400
5.
Elevated PIM2 gene expression is associated with poor survival of patients with acute myeloid leukemia.
Leuk Lymphoma
; 57(9): 2140-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26764044
6.
Modelling bladder cancer in mice: opportunities and challenges.
Nat Rev Cancer
; 15(1): 42-54, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25533675
7.
Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.
PLoS One
; 8(12): e84191, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24391908